
A medically supervised GLP-1 weight-management program — provided only after a consultation and eligibility screening, with ongoing clinical monitoring. Semaglutide is a prescription medication, and not everyone is a candidate.

Semaglutide is a prescription medication provided only after a medical consultation and eligibility screening. Individual results vary. Not everyone is a candidate.
Semaglutide is a GLP-1 medication used as part of a medically supervised weight-management program. At Pristine it is never sold as a quick fix or handed out on request. Every program begins with a medical consultation and eligibility screening, and continues with ongoing monitoring under the oversight of a double board-certified cosmetic surgeon. We will tell you honestly whether semaglutide is appropriate for you — and, just as importantly, when it is not.
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It mimics a hormone your body already makes (GLP-1) that helps regulate appetite and blood sugar.
By acting on GLP-1 receptors, semaglutide can slow gastric emptying and reduce appetite signals, which may help some people eat less and feel full sooner.
Semaglutide is a prescription medication. It is provided only after a medical consultation and eligibility screening, and only when a qualified prescriber determines it is appropriate for you.
Medication is one component of a broader, medically supervised program that includes screening, dosing guidance, and ongoing monitoring — not a standalone product.
A medically supervised program is structured, monitored, and individualized — built around clinical screening rather than a one-size-fits-all protocol.
You meet with our team to review your health history, current medications, and goals, and to determine whether a GLP-1 program is appropriate to consider.
Eligibility is assessed against medical criteria. Lab work or additional history may be requested. Not everyone is a candidate, and we will tell you if you are not.
If you are eligible, a qualified prescriber determines an appropriate medication and dosing approach for you, with clear guidance on what to expect.
Your progress, tolerance, and any side effects are monitored over time, and your plan is reviewed and adjusted under medical oversight as needed.
Before any medication is considered, every client completes a medical consultation and eligibility screening:
medical conditions, personal and family history, current medications and supplements, and any prior weight-management treatments
screening against medical criteria and contraindications to determine whether semaglutide is appropriate to consider for you
baseline labs or additional testing may be requested before a program begins
how the program is structured, what monitoring involves, and transparent pricing — explained before any decision
a qualified prescriber decides whether to proceed; there is no obligation and no pressure either way
No medication is provided until your medical consultation and eligibility screening are complete.
If appropriate, semaglutide is typically started at a low dose and adjusted gradually under medical guidance to support tolerability.
You receive clear instructions on how the medication is administered and stored, and what symptoms to watch for.
Scheduled follow-ups track your response and tolerance, and your plan is reviewed and adjusted under medical oversight.
GLP-1 medications can cause gastrointestinal side effects such as nausea, which is one reason dosing is started low and increased gradually under supervision.
Ongoing monitoring lets your provider track tolerance, adjust your plan, and address side effects early — a core reason this is a supervised medical program.
You will be told which symptoms to report and when to seek care. Always follow your provider’s instructions and the medication guide.
Semaglutide has contraindications and is not appropriate for some people. Eligibility is determined individually at your screening.
Semaglutide is a prescription medication. At Pristine it is prescribed and overseen only by licensed medical professionals holding active Florida medical credentials, under double board-certified cosmetic surgeon oversight, following a consultation and eligibility screening.
La semaglutida es un medicamento recetado de la clase GLP-1 que se utiliza dentro de un programa de control de peso con supervisión médica. Solo se ofrece después de una consulta médica y una evaluación de elegibilidad, con monitoreo continuo bajo la supervisión de un cirujano cosmético con doble certificación. Los resultados individuales varían y no todas las personas son candidatas.
Semaglutide is a prescription medication provided only after a medical consultation and eligibility screening. Individual results vary. Not everyone is a candidate.
Semaglutide is a prescription medication provided only after a medical consultation and eligibility screening. Individual results vary, and not everyone is a candidate. Book a consultation to find out whether a medically supervised GLP-1 program is right for you.